During et al., 2000 - Google Patents
An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsyDuring et al., 2000
- Document ID
- 12605245713474239899
- Author
- During M
- Symes C
- Lawlor P
- Lin J
- Dunning J
- Fitzsimons H
- Poulsen D
- Leone P
- Xu R
- Dicker B
- Lipski J
- Young D
- Publication year
- Publication venue
- Science
External Links
Snippet
The brain is generally considered immunoprivileged, although increasing examples of immunological responses to brain antigens, neuronal expression of major histocompatibility class I genes, and neurological autoimmunity have been recognized. An adeno-associated …
- 229960005486 vaccines 0 title abstract description 22
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| During et al. | An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy | |
| Gu et al. | Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction. | |
| Flach et al. | Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease | |
| Wootla et al. | Is multiple sclerosis an autoimmune disease? | |
| Hormigo et al. | Immunological and pathological study of anti‐Ri–associated encephalopathy | |
| Darnell et al. | Paraneoplastic syndromes involving the nervous system | |
| Linden et al. | Physiology of the prion protein | |
| Mabbott et al. | Prions and their lethal journey to the brain | |
| Borges et al. | Muscle-specific kinase myasthenia gravis | |
| El-Amine et al. | Mechanisms of tolerance induction by a gene-transferred peptide-IgG fusion protein expressed in B lineage cells | |
| Ling et al. | Traumatic injury and the presence of antigen differentially contribute to T-cell recruitment in the CNS | |
| Sakuma et al. | Clinicopathological study of a myelin oligodendrocyte glycoprotein-induced demyelinating disease in LEW. 1AV1 rats | |
| Ludewigs et al. | Therapeutic approaches for prion disorders | |
| JP2002535289A (en) | Vaccine-mediated treatment of neurological disorders | |
| EA009283B1 (en) | Prevention and treatment of amyloidogenic disease | |
| Fontoura et al. | Immunity to the extracellular domain of Nogo-A modulates experimental autoimmune encephalomyelitis | |
| EA013752B1 (en) | Prevention and treatment of synucleinopathic and amyloidogenic disease | |
| Horváth et al. | IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis | |
| JP2002508335A (en) | Diagnostic and therapeutic agents for infectious spongiform encephalopathy, and methods for producing non-infectious blood products and tissue-derived products | |
| JP2000507232A (en) | Vaccine compositions and methods useful for inducing immune protection against arthritogenic peptides required for the pathogenesis of rheumatoid arthritis | |
| Bolton et al. | Epitope spreading and autoimmune glomerulonephritis in rats induced by a T cell epitope of Goodpasture’s antigen | |
| Qosa et al. | The development of biological therapies for neurological diseases: moving on from previous failures | |
| Myers et al. | Peptide‐induced suppression of collagen‐induced arthritis in HLA–DR1 transgenic mice | |
| JP2004511570A (en) | Recombinant antibody fragments as autoantibody antagonists | |
| Zhu et al. | Rbm8a regulates neurogenesis and reduces Alzheimer’s disease-associated pathology in the dentate gyrus of 5× FAD mice |